2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Рекомендации ESC 2021 года по профилактике сердечно-сосудистых заболеваний в клинической практике
2021-09-24
SCID: 54.1/s4nyce2r
Discuss with AI
ESC Guidelinescardiovascular disease preventionclinical practicemedical guidelinespreventive strategies
Figures from the paper
Abstract (AI)
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication.The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.This article has been co-published with permission in the European Heart Journal and the European Journal of Preventive Cardiology.
Key Findings
1
Health professionals must consider updated public-health guidance and verify applicable drug and medical-device regulations when implementing preventive strategies.
2
The 2021 ESC Guidelines provide evidence-informed recommendations for preventing cardiovascular disease in clinical practice.
3
The guidelines reflect scientific and medical evidence available at the time of publication, but may differ from other official public-health recommendations.
4
The guidelines support, but do not replace, individualized clinical judgment and shared decision-making based on each patient’s health condition.
Research Object
cardiovascular disease prevention in clinical practice
Research Subject
preventive, diagnostic, and therapeutic medical strategies and their clinical implementation
Publication Details
Publication Date
2021-09-24
Journal
Publisher
ISSN
Cited by
598
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai20
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
The behaviour change wheel: A new method for characterising and designing behaviour change interventions2011
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
2018 ESC/ESH Guidelines for the management of arterial hypertension2018
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults2011
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2020
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease2017
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk2019
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2015
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172020
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes2008
2016 European Guidelines on cardiovascular disease prevention in clinical practice2016
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2016
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease2017
2013 ESH/ESC Guidelines for the management of arterial hypertension2013
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2020
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172018
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2019